SLC5A2 and diabetic kidney disease: This mechanism directly connects SGLT2 inhibition with the suppression of macrophage-recruiting cytokines and T cell infiltration, as MAMs-derived ROS and calcium flux are key drivers of immune cell activation in DKD.